Please enable Javascript and disable ad blockers

Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

buy

Seelos Therapeutics Inc. buy Mori8

Seelos Therapeutics Inc.

Start price

€440.70

/ 50%

Target price

14.08.15

Performance (%)

End price

€315.00

Summary

This prediction ended on with a price of €315.00. The price of Seelos Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of . Mori8 has a follow-up prediction for Seelos Therapeutics Inc. where he still thinks Seelos Therapeutics Inc. is a Buy. Mori8 has 50% into this prediction

Performance without dividends (%)

Name	1w	1m	1y	3y
Seelos Therapeutics Inc.
iShares Core DAX®
iShares Nasdaq 100
iShares Nikkei 225®
iShares S&P 500

Comments by Mori8 for this prediction

In the thread Seelos Therapeutics Inc. diskutieren

Prediction Buy

Perf. (%)

Target price 866.400

Change

Ends at

Pharma

Es hat mal über 5.- € gekostet!

zeckenjoe hat die Empfelung am 18.09.2013 beendet !

Mit dem Hauptprodukte Vitaros ® (Alprostadil 0,3% Salbe) zur Behandlung der erektilen Dysfunktion ("ED"), steht man in direkter Konkurenz zu Viagra und Co. Jedoch wird hier, anders als bei der Konkurenz, dass ganze äusserst wirksam und fast Nebenwirkungsfrei direkt da !

Mori8

0

Prediction Buy

Perf. (%)

Target price 866.400

Change

Ends at

(Vom Mitglied beendet)

Mori8

0

Current prediction by Mori8 for Seelos Therapeutics Inc.

Seelos Therapeutics Inc.

Start price

Target price

Perf. (%)

€0.15

24.11.26

50%

Stopped prediction by Mori8 for Seelos Therapeutics Inc.

Seelos Therapeutics Inc.

Start price

Target price

Perf. (%)

€1.37

25.08.26

50%

Seelos Therapeutics Inc.

Start price

Target price

Perf. (%)

€1.29

24.08.23

50%

Seelos Therapeutics Inc.

Start price

Target price

Perf. (%)

€1.26

18.08.23

50%

Seelos Therapeutics Inc.

Start price

Target price

Perf. (%)

€1.11

05.08.23

50%

Seelos Therapeutics Inc.

Start price

Target price

Perf. (%)

€1.00

15.07.23

50%

Seelos Therapeutics Inc.

Start price

Target price

Perf. (%)

€0.91

09.06.26

50%

Seelos Therapeutics Inc.

Start price

Target price

Perf. (%)

€0.80

11.06.23

50%

Seelos Therapeutics Inc.

Start price

Target price

Perf. (%)

€0.74

08.06.23

50%

Seelos Therapeutics Inc.

Start price

Target price

Perf. (%)

€0.72

03.05.26

50%

Seelos Therapeutics Inc.

Start price

Target price

Perf. (%)

€0.69

02.03.24

50%

Seelos Therapeutics Inc.

Start price

Target price

Perf. (%)

€0.67

27.02.26

50%

Seelos Therapeutics Inc.

Start price

Target price

Perf. (%)

€0.82

15.02.26

50%

Seelos Therapeutics Inc.

Start price

Target price

Perf. (%)

€0.90

03.08.24

50%

Seelos Therapeutics Inc.

Start price

Target price

Perf. (%)

€0.62

24.06.23

50%

Seelos Therapeutics Inc.

Start price

Target price

Perf. (%)

€0.75

09.06.23

50%

Seelos Therapeutics Inc.

Start price

Target price

Perf. (%)

€0.097

-

50%

Seelos Therapeutics Inc.

Start price

Target price

Perf. (%)

€1.44

23.12.22

50%

Seelos Therapeutics Inc.

Start price

Target price

Perf. (%)

€1.53

05.12.22

50%

Seelos Therapeutics Inc.

Start price

Target price

Perf. (%)

€2.02

14.07.22

50%

Seelos Therapeutics Inc.

Start price

Target price

Perf. (%)

€0.49

04.11.21

50%

Seelos Therapeutics Inc.

Start price

Target price

Perf. (%)

€1.90

09.03.20

50%

Seelos Therapeutics Inc.

Start price

Target price

Perf. (%)

€3.18

30.05.19

50%

Seelos Therapeutics Inc.

Start price

Target price

Perf. (%)

€5.82

25.01.19

50%

Seelos Therapeutics Inc.

Start price

Target price

Perf. (%)

€32.49

09.01.19

50%

Seelos Therapeutics Inc.

Start price

Target price

Perf. (%)

€57.64

18.01.17

50%